Table 2.
Angiographic and procedural characteristics.
Reference (trial), year | PCI technique | Sample size | LM (%) | LAD (%) | LCX (%) | RCA (%) | True bifurcation (%) | SB (mm), mean ± SD | FKBI (%) |
---|---|---|---|---|---|---|---|---|---|
Chen et al (DKCRUSH-II),8 2011 | DK | 185 | 33 (18) | 112 (61) | 23 (12) | 17 (9) | 185 (100) | 15.3 ± 11.1 | 183 (100) |
Pro | 185 | 29 (16) | 110 (60) | 30 (16) | 16 (9) | 185 (100) | 14.6 ± 11.9 | 144 (79) | |
Ruiz et al,22 2013 | Pro | 33 | 0 | 24 (71) | 9 (26) | 1 (3) | 27 (79) | NA | 14 (42) |
T stent | 36 | 0 | 26 (72) | 6 (17) | 4 (11) | 33 (92) | NA | 23 (64) | |
Ye et al,23 2012 | Pro | 30 | 0 | 53 (78) | 10 (15) | 5 (7) | 37 (100) | 10.2 ± 8.4 | 26 (87) |
DK | 38 | 38 (100) | 16.9 ± 8.2 | 38 (100) | |||||
Chen et al (DKCRUSH-III),24 2015 | DK | 208 | 210 (100) | 0 | 0 | 0 | 210 (100) | 16.5 ± 11.1 | 209 (99) |
Culotte | 207 | 209 (100) | 0 | 0 | 0 | 209 (100) | 17.0 ± 13.0 | 208 (99) | |
Kim et al (PERFECT),25 2015 | Crush | 213 | 0 | 200 (94) | 10 (5) | 3 (1) | 194 (91) | 10.3 ± 8.2 | 204 (96) |
Pro | 206 | 0 | 190 (92) | 15 (7) | 1 (0) | 169 (82) | 8.3 ± 7.3 | 163 (79) | |
Kumsars et al (NBBS IV),26 2015 | Pro | 220 | 6 (3) | 161 (74) | 36 (17) | 14 (7) | 218 (100) | 6.4 ± 4.1 | 79 (36) |
Culotte | 228 | 3 (1) | 174 (77) | 40 (18) | 9 (4) | 228 (100) | 7.7 ± 4.9 | 208 (91) | |
Hildick-Smith et al (EBC TWO),27 2016 | Pro | 103 | 0 | 80 (78) | 16 (15) | 6 (6) | 103 (100) | 9.7 (SD7.1) | 97 (94) |
Culotte | 97 | 0 | 75 (77) | 18 (19) | 4 (4) | 97 (100) | 10.8 (SD7.3) | 93 (96) | |
Ferenc et al (BBK II),28 2016 | Culotte | 150 | 28 (19) | 82 (55) | 36 (24) | 4 (3) | 147 (98) | 13.8 ± 6.6 | NA |
TAP | 150 | 23 (15) | 83 (55) | 38 (25) | 6 (4) | 143 (95) | 15.5 ± 6.9 | NA | |
Zhang et al,29 2016 | Pro | 52 | 16 (31) | 33 (63) | 3 (6) | 0 | 52 (100) | 12.8 ± 4.9 | 43 (83) |
Culotte | 52 | 14 (27) | 34 (65) | 2 (4) | 2 (4) | 52 (100) | 14.1 ± 7.1 | 48 (92) | |
Chen et al (DKCRUSH-V),9 2019 | DK | 240 | 242 (100) | 0 | 0 | 0 | 242 (100) | NA | 239 (99) |
Pro | 242 | 242 (100) | 0 | 0 | 0 | 242 (100) | NA | 191 (79) | |
Zhang et al (DEFINITION II),10 2020 | Pro | 325 | 94 (29) | 197 (61) | 25 (8) | 9 (3) | 315 (97) | 19.9 ± 9.3 | 109 (34) patients underwent first kissing balloon inflation after first stent implantation. 73 (23) patients underwent 2 stent technique, and 70 (22) underwent FKBI. |
2 stent | 328 | 94 (29) | 205 (63) | 17 (5) | 12 (4) | 325 (99) | 20.7 ± 10.1 | 287 (99) | |
Kim et al (SMART STRATEGY II),30 2020 | Pro | 23 | 23 (100) | 0 | 0 | 0 | 23 (100) | NA | 16 (70) |
2 stent | 23 | 23 (100) | 0 | 0 | 0 | 23 (100) | NA | 22 (96) | |
Hildick-Smith et al (EBC MAIN),14 2021 | Pro | 230 | 230 (100) | 0 | 0 | 0 | 227 (99) | 5.8 ± 4.0 | 202 (89) patients underwent first kissing balloon inflation after first stent implantation. 51 (22) patients underwent 2 stent technique and underwent FKBI. |
2 stent | 237 | 237 (100) | 0 | 0 | 0 | 237 (100) | 7.9 ± 5.7 | 217 (93) |
FKBI, final kissing balloon inflation; LAD, left anterior descending artery; LCX, left circumflex artery; LM, left main; NA, not available; PCI, percutaneous coronary intervention; Pro, provisional; RCA, right coronary artery; SB, side branch.